NASDAQ:VIVE - Viveve Medical Stock Price, Forecast & News

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

Viveve Medical Inc (NASDAQ:VIVE) posted its quarterly earnings results on Thursday, November, 7th. The company reported ($13.51) earnings per share for the quarter, topping the consensus estimate of ($16.00) by $2.49. The business earned $1.05 million during the quarter. Viveve Medical had a negative net margin of 429.71% and a negative return on equity of 2,979.48%. View Viveve Medical's Earnings History.

Viveve Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Viveve Medical.

6 Wall Street analysts have issued 1 year price targets for Viveve Medical's shares. Their forecasts range from $0.20 to $6.00. On average, they expect Viveve Medical's share price to reach $2.24 in the next year. This suggests a possible upside of 166.7% from the stock's current price. View Analyst Price Targets for Viveve Medical.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Viveve Medical.

Media headlines about VIVE stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Viveve Medical earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Viveve Medical.

Viveve Medical saw a increase in short interest during the month of November. As of November 15th, there was short interest totalling 249,300 shares, an increase of 79.0% from the October 31st total of 139,300 shares. Based on an average daily trading volume, of 710,700 shares, the days-to-cover ratio is currently 0.4 days. Approximately 17.3% of the shares of the stock are short sold. View Viveve Medical's Current Options Chain.

Some companies that are related to Viveve Medical include Nexeon Medsystems (NXNN), CHF Solutions (CHFS), ReShape Lifesciences (RSLSD), Escalon Medical (ESMC), Trimedyne (TMED), SpectraScience (SCIE), Guided Therapeutics (GTHP), Magna-Lab (MAGAA), Newcardio (NWCI), Echo Therapeutics (ECTE), 21st North (ULGX) and IMRIS (IMRSQ).

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), Fortive (FTV), HP (HPQ), Lowe's Companies (LOW), Western Digital (WDC), Viking Therapeutics (VKTX), Quantenna Communications (QTNA), SCYNEXIS (SCYX) and Synergy Pharmaceuticals (SGYP).

(VIVE) raised $13 million in an IPO on Tuesday, June 14th 2016. The company issued 1,600,000 shares at $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.

Viveve Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include FNY Investment Advisers LLC (1.10%). View Institutional Ownership Trends for Viveve Medical.

VIVE stock was acquired by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC. View Insider Buying and Selling for Viveve Medical.

Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VIVE stock can currently be purchased for approximately $0.84.

Viveve Medical has a market capitalization of $1.24 million and generates $18.52 million in revenue each year. The company earns $-49,320,000.00 in net income (profit) each year or ($161.00) on an earnings per share basis. Viveve Medical employs 67 workers across the globe.View Additional Information About Viveve Medical.

The official website for Viveve Medical is http://www.viveve.com/.

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected]